References
- Acedo JZ, Reyes CT, Rodriguez EB. 2012. Chemical composition of purslane (Portulaca oleracea L.) and anti-inflammatory activity of its lipid components. Philipp J Crop Sci. 37(2):13–19.
- Bag-Ozbek A, Giles JT. 2015. Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship? Curr Allergy Asthma Rep. 15(2):497.
- Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MNM, Habibullah M, Attas A. 2000. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J Ethnopharmacol. 73(3):445–451.
- Cui XY, Ying ZM, Ying XX, Jia LQ, Yang GL. 2021. Three new alkaloids from Portulaca oleracea L. and their bioactivities. Fitoterapia. 154:105020.
- Duan Y, Ying ZM, Zhang MB, Ying XX, Yang GL. 2020. Two new homoisoflavones from Portulaca oleracea L. and their activities. Nat Prod Res. 1–9. doi:10.1080/14786419.2020.1815742
- Guil-Guerrero JL, Rodríguez-García I. 1999. Lipids classes, fatty acids and carotenes of the leaves of six edible wild plants. Eur Food Res Technol. 209(5):313–316.
- Gu YY, Leng AJ, Zhang WJ, Ying XX, Stien D. 2020. A novel alkaloid from Portulaca oleracea L. and its anti-inflammatory activity. Nat Prod Res. 1–6.doi: 10.1080/14786419.2020.1795855
- Lee AS, Kim JS, Lee YJ, Kang DG, Lee HS. 2012. Anti-TNF-α activity of Portulaca oleracea in vascular endothelial cells. Int J Mol Sci. 13(5):5628–5644.
- Li CY, Meng YH, Ying ZM, Xu N, Hao D, Gao MZ, Zhang WJ, Xu L, Gao YC, Ying XX. 2016. Three novel alkaloids from Portulaca oleracea L. and their anti-inflammatory effects. J Agric Food Chem. 64(29):5837–5844.
- Lim YY, Quah EPL. 2007. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem. 103(3):734–740.
- Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhang R. 2000. Fatty acids and b-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr A. 893(1):207–213.
- Liu XL, Wu HB, Tao XJ, Ying XX, Stien D. 2021. Two amide glycosides from Portulaca oleracea L. and its bioactivities. Nat Prod Res. 35(16):2655–2659.
- Ma YF, Bao YR, Zhang WJ, Ying XX, Stien D. 2020. Four lignans from Portulaca oleracea L. and its antioxidant activities. Nat Prod Res. 34(16):2276–2282.
- Magne D, Bessueille L. 2015. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes. Cell Mol Life Sci. 72(13):2475–2489.
- Meng YH, Ying ZM, Xiang Z, Hao D, Zhang WJ, Zheng Y, Gao YC, Ying XX. 2016. The anti-inflammation and pharmacokinetics of a novel alkaloid from Portulaca oleracea L. J Pharm Pharmacol. 68(3):397–405.
- Okafor IA, Ayalokunrin MB, Orachu LA. 2014. A review on Portulaca oleracea (Purslane) plant its nature and biomedical benefits. Int J Biomed Res. 5(2):75.
- Raghavendra KR, Kumar KA, Shashikanth S. 2015. An efficient synthesis of new lignan scaffolds as antimicrobial inhibition agents. J Chem Pharm Res. 7(8):638–644.
- Sharma A, Kaithwas G, Vijayakumar M, Unnikrishnan MK, Rao CV. 2012. Antihyperglycemic and antioxidant potential of polysaccharide fraction from Portulaca oleracea seeds against streptozotocin-induced diabetes in rats. J Food Biochem. 36(3):378–382.
- The Pharmacopoeia Commission of PRC. 2020. The pharmacopoeia of the People’s Republic of China (Part 1). Beijing (China): China Medical Science and Technology Press; p. 51–52.
- Winter JM, Jansma AL, Handel TM, Moore BS. 2009. Formation of the pyridazine natural product azamerone by biosynthetic rearrangement of an aryl diazoketone. Angew Chem Int Ed Engl. 48(4):767–770.
- Xu W, Wang JH, Ju BZ, Lan XJ, Ying XX, Stien D. 2021. Seven compounds from Portulaca oleracea L. and their anticholinesterase activities. Nat Prod Res. 1–7. doi:10.1080/14786419.2021.1916928.
- Yang X, Zhang WJ, Ying XX, Stien D. 2018. New flavonoids from Portulaca oleracea L. and their activities. Fitoterapia. 127:257–262.